Plexus Corp.'s SEC filings document operating results, financial condition, governance matters and material corporate events for its complex product design, manufacturing and services business. Recent 8-K reports furnish quarterly and fiscal-year earnings releases and related financial information for the company's product lifecycle operations across regulated end markets.
The filings also record shareholder meeting results, including director elections, advisory executive compensation votes and auditor ratification, as well as officer transition and compensation-arrangement disclosures. These records describe formal governance actions, executive roles and recurring public-company reporting obligations for PLXS.
Plexus Corp regional president Victor Tan reported selling Plexus common stock in two open-market transactions on February 6, 2026. He sold 1,000 shares at $205.00 per share and 2,000 shares at $205.75 per share, with the latter price reported as a weighted average from trades between $205.50 and $206.00.
After these sales, Tan directly beneficially owned 11,435 Plexus shares. The filing notes he will provide full trade details, including individual prices and share amounts, to regulators, the company, or shareholders upon request.
Plexus Corp. chairman Dean A. Foate, a director and Chairman of the Board, reported insider transactions in Plexus Corp. common stock.
On February 6, 2026, he sold 10,000 shares of common stock at $205 per share, leaving him with 99,429 shares held directly. He also has 15,000 shares held indirectly in a trust for which he is trustee.
Separately, on February 9, 2026, he received a grant of 1,008 Restricted Stock Units under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents one share of common stock and these units vest on February 9, 2027.
Plexus Corp executive Angelo Michael Ninivaggi Jr., Exec VP, CAO, General Counsel and Secretary, reported a sale of Plexus common stock. On February 5, 2026, he sold 4,303 shares of common stock at a price of $203.06 per share. After this transaction, he directly beneficially owned 20,099 shares of Plexus common stock.
Plexus Corp. executive Patrick J. Jermain, Exec. VP & CFO, reported a sale of common stock. On February 4, 2026, he sold 3,587 shares of Plexus Corp. common stock at $204.09 per share.
After this transaction, he directly owned 16,882 shares of Plexus common stock. In addition, 3,719 shares were held indirectly in the Plexus Corp. 401(k) Retirement Plan, based on the latest report from the plan’s trustee.
A shareholder of PLXS has filed a notice of proposed sale under Rule 144 for 3,000 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $616,500.00, on or about 02/06/2026 on the NASDAQ exchange.
The securities were previously acquired from the issuer as performance shares, including 1,623 shares on 11/13/2024 and 1,377 shares on 02/11/2025. The notice states that the filer is not aware of undisclosed material adverse information about the issuer’s operations.
Plexus Corp. reported fiscal Q1 2026 net sales of $1.07 billion, up about 10% from $976.1 million a year earlier, driven mainly by stronger demand in the AMER region and the Healthcare/Life Sciences sector.
Net income rose to $41.2 million from $37.3 million, with diluted EPS increasing to $1.51 from $1.34. Gross margin slipped to 9.9% from 10.3% as higher fixed costs offset some of the sales growth, while operating margin improved to 5.1% from 4.8% helped by lower restructuring charges.
Free cash flow was negative $50.6 million as the company invested in inventory to support program ramps and raised capital spending. Plexus ended the quarter with $249.4 million in cash and cash equivalents and $158.0 million in debt, finance lease and other financing obligations, and repurchased 152,987 shares for $22.4 million under its 2026 buyback program.
Plexus Corp. director Jennifer Wuamett reported the vesting of restricted stock units into common shares. On February 3, 2026, 1,370 restricted stock units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of common stock. Following this transaction, she directly owns 3,349 shares of Plexus common stock.
Plexus Corp director Michael V. Schrock reported the vesting of equity awards that delivered 1,370 shares of common stock. The shares came from Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which vested and settled on February 3, 2026.
Following this transaction, Schrock directly held 44,329 shares of Plexus common stock. The RSUs were exercised at an effective price of $0.00 per unit, consistent with stock-based compensation rather than an open-market purchase.
Plexus Corp director Paul A. Rooke reported the vesting of restricted stock units that converted into common shares. On February 3, 2026, 1,370 Restricted Stock Units granted under the Plexus Corp 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of common stock at a stated price of $0 per share. Following this equity award settlement, Rooke directly holds 15,991 shares of Plexus common stock.
Plexus Corp. director Karen Marie Rapp reported the vesting of equity awards and the corresponding issuance of common shares. On February 3, 2026, 1,370 Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of Plexus common stock at an exercise price of $0.00 per share. Following this conversion, she directly beneficially owned 9,035 shares of Plexus common stock.